US Drug Recall Register
Class III · Low risk Completed Initiated Mar 27, 2024 (2 years ago)

NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.

What was recalled

NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor, MI 48108, NDC 72426-818-03

Recalling firm
Esperion
NDC code
72426-818-03
Origin
MI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0441-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ezetimibe recalls

See all